Lumida
/PACS
⌘K
Pacs Group Inc

Pacs Group Inc

PACS
$46.13USD+1.10%+0.50 today

MARKET CAP

7.3B

P/E (TTM)

31.1x

FWD P/E

19.6x

DAY RANGE

$44 – $47

52W RANGE

$8
$47

AI Summary

Stalk
StalkMedium

PACS remains in a Stage 2 advancing uptrend with structural higher highs and higher lows above rising EMAs, but recent Bullish Exhaustion and extreme overbought conditions warrant deferred execution. Await pullbacks into the 9/21 EMA zone or consolidation acceptance before entering, acknowledging moderate Stage 2→3 transition risk.

  • 11% YoY Q1 revenue growth to $1.42 B, driven by occupancy gains
  • 75% YoY adjusted EBITDA surge to $170.4 M, boosting margins
  • Q1 cost of services rose 25% YoY, squeezing margins
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

PACS Group, Inc. (NASDAQ: PACS) is a leading provider of skilled nursing and assisted living services in the U.S., operating a significant network across 323 facilities with approximately 35,500 beds. The company specializes in delivering post-acute care, capitalizing on favorable demographic trends of an aging population that demands high-quality healthcare solutions. PACS is particularly noted for its strategic acquisition of additional facilities, expanding its footprint and operational capacity, amid the backdrop of a fragmented healthcare market facing increasing regulatory scrutiny and operational complexities.

Bull says

  • 11% YoY Q1 revenue growth to $1.42 B, driven by occupancy gains
  • 75% YoY adjusted EBITDA surge to $170.4 M, boosting margins
  • 3,633 skilled nursing beds added via six-state acquisitions
  • Occupancy at 90.9% vs. 79% industry average, signaling strong demand
  • $800 M liquidity with 0.1x net leverage and $250 M buyback
  • High momentum and growth factors support further expansion

Bear says

  • Q1 cost of services rose 25% YoY, squeezing margins
  • Negative profitability and quality factors indicate margin and balance-sheet stress
  • High leverage raises refinancing risk amid rising rates
  • Regulatory scrutiny on reimbursements threatens revenue stability
  • Labor shortages and wage hikes could inflate operating costs
  • Aggressive acquisitions may face integration hiccups

Investment themes with PACS

Health Care Providers -0.61%

UNH · CVS · HCA

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-13-2026neutral

Transcript signals

Bull points

  • We're very pleased to report a strong start to 2026 with continued operational consistency across our platform and measurable progress across the facilities we've integrated over this past several years.
  • Our performance this quarter reflects both the durability of our operating model and the continued execution of our teams across the organization, as well as the strength of the foundation we built throughout 2025.
  • We believe the scale and geographic diversity of our platform combined with the consistency of our operating model position us to deliver reliable performance while continuing to grow thoughtfully over time.

Bear points

  • I'd like to take a moment to briefly address our previously disclosed government investigations. These matters continue to progress through the normal course, and we remain fully cooperative and engaged with the government throughout the process. While we were unable to estimate the timing of resolution at this stage, we are confident in our ability to navigate these matters responsibly and thoughtfully, just as we have navigated other challenges throughout our company's history.
  • The payment we received in the first quarter of 2026 was the last payment related to the 2024 program year.
  • the W-EQUIP payments received in the first quarter of 26 were not included in original guidance and will continue to treat these future expected payments in the same way, excluding them from guidance.
Read full transcript analysis ›